1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid

C89H111N21O7 — CID 158117484

IUPAC1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid
SMILESCN(C)CCCn1c(N)nc2ccccc21.CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CC2(CCN(C)CC2)CNC4=O)nc2ccccc21.CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CC2(CCNCC2)CNC4=O)nc2ccccc21.CN1CCC2(CC1)CNC(=O)c1cc3ccc(C(=O)O)cc3n1C2
InChIInChI=1S/C30H37N7O2.C29H35N7O2.C18H21N3O3.C12H18N4/c1-34(2)13-6-14-36-24-8-5-4-7-23(24)32-29(36)33-27(38)22-10-9-21-17-26-28(39)31-19-30(11-15-35(3)16-12-30)20-37(26)25(21)18-22;1-34(2)14-5-15-35-23-7-4-3-6-22(23)32-28(35)33-26(37)21-9-8-20-16-25-27(38)31-18-29(10-12-30-13-11-29)19-36(25)24(20)17-21;1-20-6-4-18(5-7-20)10-19-16(22)15-8-12-2-3-13(17(23)24)9-14(12)21(15)11-18;1-15(2)8-5-9-16-11-7-4-3-6-10(11)14-12(16)13/h4-5,7-10,17-18H,6,11-16,19-20H2,1-3H3,(H,31,39)(H,32,33,38);3-4,6-9,16-17,30H,5,10-15,18-19H2,1-2H3,(H,31,38)(H,32,33,37);2-3,8-9H,4-7,10-11H2,1H3,(H,19,22)(H,23,24);3-4,6-7H,5,8-9H2,1-2H3,(H2,13,14)
InChIKeyFREPZDDSJGOZOX-UHFFFAOYSA-N
MW1587.01 g/mol
LogP10.32
Rot. Bonds17

About 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid

1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid (PubChem CID 158117484) has the molecular formula C89H111N21O7 and a molecular weight of 1587.01 g/mol. Its IUPAC name is 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid.

Molecular Properties

Compound Name1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid
PubChem CID158117484
Molecular FormulaC89H111N21O7
Molecular Weight1587.01 g/mol
Exact Mass1585.90
IUPAC Name1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid
SMILESCN(C)CCCn1c(N)nc2ccccc21.CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CC2(CCN(C)CC2)CNC4=O)nc2ccccc21.CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CC2(CCNCC2)CNC4=O)nc2ccccc21.CN1CCC2(CC1)CNC(=O)c1cc3ccc(C(=O)O)cc3n1C2
InChIInChI=1S/C30H37N7O2.C29H35N7O2.C18H21N3O3.C12H18N4/c1-34(2)13-6-14-36-24-8-5-4-7-23(24)32-29(36)33-27(38)22-10-9-21-17-26-28(39)31-19-30(11-15-35(3)16-12-30)20-37(26)25(21)18-22;1-34(2)14-5-15-35-23-7-4-3-6-22(23)32-28(35)33-26(37)21-9-8-20-16-25-27(38)31-18-29(10-12-30-13-11-29)19-36(25)24(20)17-21;1-20-6-4-18(5-7-20)10-19-16(22)15-8-12-2-3-13(17(23)24)9-14(12)21(15)11-18;1-15(2)8-5-9-16-11-7-4-3-6-10(11)14-12(16)13/h4-5,7-10,17-18H,6,11-16,19-20H2,1-3H3,(H,31,39)(H,32,33,38);3-4,6-9,16-17,30H,5,10-15,18-19H2,1-2H3,(H,31,38)(H,32,33,37);2-3,8-9H,4-7,10-11H2,1H3,(H,19,22)(H,23,24);3-4,6-7H,5,8-9H2,1-2H3,(H2,13,14)
InChIKeyFREPZDDSJGOZOX-UHFFFAOYSA-N
XLogP10.32
TPSA305.30 Ų
H-Bond Donors8
H-Bond Acceptors22
Rotatable Bonds17
Heavy Atoms117
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001587.01
LogP ≤ 510.32
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1022

Analyze 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

ethyl 4-[2-(9-oxo-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-2-yl)ethyl]benzoate;2-[2-(4-ethylphenyl)ethyl]-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-9-one;N-[2-(4-methylphenyl)ethyl]-3-(9-oxo-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-2-yl)propanamide;2-(1-methylpyrrol-2-yl)-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-9-one;2-[2-[4-(pyrrolidin-1-ylmethyl)phenyl]ethyl]-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-9-one
CID 90863620
6-[2-Carbazol-9-id-1-yl-1-(3,5-dimethylphenyl)benzimidazol-4-yl]-4-(3,5-dimethylphenyl)pyridine-2-carboxylic acid;6-[2-carbazol-9-id-1-yl-1-(3-phenylphenyl)benzimidazol-4-yl]-4-(3,5-dimethylphenyl)pyridine-2-carboxylic acid;6-(2-carbazol-9-id-1-yl-1-propan-2-ylbenzimidazol-4-yl)-4-(3,5-dimethylphenyl)pyridine-2-carboxylic acid;6-(2-carbazol-9-id-1-yl-1-propan-2-ylbenzimidazol-4-yl)-4-phenylpyridine-2-carboxylic acid;platinum
CID 157518015
8-[2-[3-(1H-imidazol-5-yl)phenyl]acetyl]-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]benzimidazol-1-one;8-[2-[3-(1-methylimidazol-4-yl)phenyl]acetyl]-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]benzimidazol-1-one;1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]benzimidazole-8-carboxylic acid
CID 157567133
ethyl 4-[2-(9-oxo-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-2-yl)ethyl]benzoate;2-[2-(4-ethylphenyl)ethyl]-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-9-one;methyl 2-[3-(9-oxo-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-2-yl)propanoylamino]-3-phenylpropanoate;N-[2-(4-methylphenyl)ethyl]-3-(9-oxo-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-2-yl)propanamide
CID 157615150
17-cyclohexyl-3,6,10-triazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(17),2,4,11(16),12,14-hexaene-13-carboxylic acid;methane;methyl (E)-3-[4-[[1-[(17-cyclohexyl-3,6,10-triazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(17),2,4,11(16),12,14-hexaene-13-carbonyl)amino]cyclopentanecarbonyl]amino]phenyl]prop-2-enoate
CID 157783511
Sodium;2-[2-(4-acetylphenyl)ethyl]-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-9-one;ethyl 4-[2-(9-oxo-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-2-yl)ethyl]benzoate;4-[2-(9-oxo-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-2-yl)ethyl]benzoic acid;hydroxide
CID 157920396
2-[(5-benzyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)methyl]-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-9-one;2-[(dimethylamino)methyl]-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-9-one;N-[3-(dimethylamino)propyl]-N-methyl-3-(9-oxo-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-2-yl)benzamide;methyl 3-(4-hydroxyphenyl)-2-[3-(9-oxo-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-2-yl)propanoylamino]propanoate
CID 158278220
ethyl 4-[2-benzoylimino-6-(hydroxymethyl)-3H-indol-1-yl]cyclohexane-1-carboxylate;ethyl 4-[6-(hydroxymethyl)-2-[(4-methylbenzoyl)amino]benzimidazol-1-yl]cyclohexane-1-carboxylate;N-[6-ethyl-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;N-[6-(hydroxymethyl)-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;methyl 4-[2-benzamido-6-(hydroxymethyl)benzimidazol-1-yl]cyclohexane-1-carboxylate;methyl 4-[6-(hydroxymethyl)-2-(4-methylbenzoyl)imino-3H-indol-1-yl]cyclohexane-1-carboxylate
CID 158549323
17-cyclohexyl-3-(2-trimethylsilylethoxymethyl)-3,5,10-triazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(17),2(6),4,11(16),12,14-hexaene-13-carboxylic acid;methyl (E)-3-[4-[[1-[[17-cyclohexyl-3-(2-trimethylsilylethoxymethyl)-3,5,10-triazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(17),2(6),4,11(16),12,14-hexaene-13-carbonyl]amino]cyclopentanecarbonyl]amino]phenyl]prop-2-enoate
CID 158847322
9-Acetyl-2-[1-(cyclopropylmethyl)indol-2-yl]-1,3,9-triazatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraene-6-carboxylic acid;2-[1-(cyclopropylmethyl)indol-2-yl]-1,3,9-triazatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraene-6-carboxylic acid;methyl 2-[1-(cyclopropylmethyl)indol-2-yl]-1,3,9-triazatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraene-6-carboxylate
CID 159031324
6-[2-Carbazol-9-id-1-yl-1-(3,5-dimethylphenyl)benzimidazol-4-yl]pyridine-2-carboxylic acid;6-(2-carbazol-9-id-1-yl-1-methylbenzimidazol-4-yl)-4-phenylpyridine-2-carboxylic acid;6-(2-carbazol-9-id-1-yl-1-methylbenzimidazol-4-yl)pyridine-2-carboxylic acid;6-(2-carbazol-9-id-1-yl-1-phenylbenzimidazol-4-yl)-4-(3,5-dimethylphenyl)pyridine-2-carboxylic acid;platinum
CID 159265820
21-cyclohexyl-N-(dimethylsulfamoyl)-10-methyl-8,11,14-triazapentacyclo[12.7.0.02,7.08,12.015,20]henicosa-1(21),2,4,6,9,11,15(20),16,18-nonaene-17-carboxamide;21-cyclohexyl-N-(dimethylsulfamoyl)-8,11,14-triazapentacyclo[12.7.0.02,7.08,12.015,20]henicosa-1(21),2,4,6,9,11,15(20),16,18-nonaene-17-carboxamide;21-cyclohexyl-10-methyl-8,11,14-triazapentacyclo[12.7.0.02,7.08,12.015,20]henicosa-1(21),2,4,6,9,11,15(20),16,18-nonaene-17-carboxylic acid;21-cyclohexyl-8,11,14-triazapentacyclo[12.7.0.02,7.08,12.015,20]henicosa-1(21),2,4,6,9,11,15(20),16,18-nonaene-17-carboxylic acid;methane
CID 159268795

Frequently Asked Questions

What is the IUPAC name of 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid?
The IUPAC name of 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid (CID 158117484) is 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid.
What is the SMILES notation for 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid?
The canonical SMILES for 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid is CN(C)CCCn1c(N)nc2ccccc21.CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CC2(CCN(C)CC2)CNC4=O)nc2ccccc21.CN(C)CCCn1c(NC(=O)c2ccc3cc4n(c3c2)CC2(CCNCC2)CNC4=O)nc2ccccc21.CN1CCC2(CC1)CNC(=O)c1cc3ccc(C(=O)O)cc3n1C2.
What is the InChIKey of 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid?
The InChIKey is FREPZDDSJGOZOX-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H37N7O2.C29H35N7O2.C18H21N3O3.C12H18N4/c1-34(2)13-6-14-36-24-8-5-4-7-23(24)32-29(36)33-27(38)22-10-9-21-17-26-28(39)31-19-30(11-15-35(3)16-12-30)20-37(26)25(21)18-22;1-34(2)14-5-15-35-23-7-4-3-6-22(23)32-28(35)33-26(37)21-9-8-20-16-25-27(38)31-18-29(10-12-30-13-11-29)19-36(25)24(20)17-21;1-20-6-4-18(5-7-20)10-19-16(22)15-8-12-2-3-13(17(23)24)9-14(12)21(15)11-18;1-15(2)8-5-9-16-11-7-4-3-6-10(11)14-12(16)13/h4-5,7-10,17-18H,6,11-16,19-20H2,1-3H3,(H,31,39)(H,32,33,38);3-4,6-9,16-17,30H,5,10-15,18-19H2,1-2H3,(H,31,38)(H,32,33,37);2-3,8-9H,4-7,10-11H2,1H3,(H,19,22)(H,23,24);3-4,6-7H,5,8-9H2,1-2H3,(H2,13,14).
What are the key properties of 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid?
1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid has a molecular weight of 1587.01 g/mol, XLogP of 10.32, 17 rotatable bonds, 8 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-(dimethylamino)propyl]benzimidazol-2-amine;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;N-[1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxamide;1'-methyl-1-oxospiro[3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-4,4'-piperidine]-8-carboxylic acid is sourced from PubChem (CID 158117484), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).